ACADIA Pharmaceuticals Inc. acquired Levo Therapeutics, Inc.
ACADIA Pharmaceuticals Inc. (NasdaqGS:ACAD) completed the acquisition of Levo Therapeutics, Inc. on June 2, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.77 USD | +0.68% |
|
+10.17% | -43.24% |
1st Jan change | Capi. | |
---|---|---|
-43.24% | 2.94B | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |